Molecular genetics of thyroid cancer
M Rebaї, A Rebaї - Genetics research, 2016 - cambridge.org
The pathogenesis of the development and progression of thyroid cancer (TC) is far from
being clear at present. Accumulated evidence suggests that it is a complex polygenic …
being clear at present. Accumulated evidence suggests that it is a complex polygenic …
BRAF mutations in an Italian regional population: implications for the therapy of thyroid cancer
Background. Molecular diagnostics has offered new techniques for searching for mutations
in thyroid indeterminate lesions. The study's aim was to evaluate the BRAF mutations' …
in thyroid indeterminate lesions. The study's aim was to evaluate the BRAF mutations' …
Relationship of Recurrence Rate with some Characteristics in Patients with Thyroid Carcinoma
BDM Tri, BDP Chi, BT Hiep, NH Trung… - Indian Journal of …, 2023 - journals.lww.com
Background: Determining the clinical and subclinical characteristics related to the
recurrence status in patients with a thyroid carcinoma has great significance for prognosis …
recurrence status in patients with a thyroid carcinoma has great significance for prognosis …
Relations Between Pathological Markers and Radioiodine Scan and 18F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal …
JW Lee, HS Min, SM Lee, HW Kwon… - Nuclear medicine and …, 2015 - Springer
Purpose The aim of this study was to investigate relationships between the
immunohistochemical results and radioiodine scan and 18 F-FDG PET findings in papillary …
immunohistochemical results and radioiodine scan and 18 F-FDG PET findings in papillary …
Genetic-targeted therapy of thyroid cancer: a real promise
M Xing - Thyroid, 2009 - liebertpub.com
The Ras? Raf? MEK? MAP kinase/ERK signaling pathway (MAP kinase pathway) plays a
fundamental role in cell cycling, proliferation, and survival and, when aberrantly activated …
fundamental role in cell cycling, proliferation, and survival and, when aberrantly activated …
Does molecular genotype provide useful information in the management of radioiodine refractory thyroid cancers? Results of a retrospective study
C de la Fouchardiere, N Oussaid, O Derbel… - Targeted …, 2016 - Springer
Introduction Whether mutation status should be used to guide therapy is an important issue
in many cancers. We correlated mutation profile in radioiodine-refractory (RAIR) metastatic …
in many cancers. We correlated mutation profile in radioiodine-refractory (RAIR) metastatic …